CeriBell, Inc. CBLL
At closeNov 5, 2026, 4:00 PM EST
After hours · Nov 5, 4:00 PM ET
- YTD
- +18.60%
- 1 year
- +120.80%
- Market cap
- 1.01B
- Revenue (ttm)
- 108.72M
- Profit margin
- -67.96%
- EPS (ttm)
- -1.95
- Shares out
- 38.84M
- Forward P/E
- -16.00
- YTD return
- +18.60%
- 1-year return
- +120.80%
- Volume
- 920.14K
- Avg volume
- 459.94K
- Open
- 27.57
- Previous close
- 27.39
- Day's range
- 25.81 – 28.00
- 52-week range
- 11.27 – 28.89
- Beta
- 0.86
- Analysts
- Strong Buy
- Price target
- 29.57 (+13.7%)
- Earnings date
- Feb 23, 2027
2Y -1.02 (-3.78%)
Key statistics
- Enterprise value
- 967.87M
- PEG ratio
- 0.00
- Price / sales
- 9.29
- Price / book
- 8.59
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 29.90%
- Free cash flow
- -33.01M
- Total cash
- 117.47M
- Total debt
- 21.65M
- Return on equity
- -52.47%
- Short % of float
- 8.46%
- 50-day average
- 25.13
- 200-day average
- 20.86
Analyst view
Consensus: strong buy
- Target (low)
- 26.00
- Target (mean)
- 29.57
- Target (high)
- 33.00
- Strong buy1
- Buy7
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 23, 2027
Expected Feb 23, 2027. Consensus EPS estimate -0.44.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 23, 2027 | Dec 30, 2026 | -0.46345 | — | — | — |
| Nov 3, 2026 | Sep 30, 2026 | -0.51001 | -0.55 | -0.04 | -7.84% |
| Aug 10, 2026 | Jun 30, 2026 | -0.47119 | -0.51 | -0.04 | -8.24% |
| May 11, 2026 | Mar 31, 2026 | -0.39 | -0.52 | -0.13 | -33.33% |
| Feb 24, 2026 | Dec 31, 2025 | -0.43 | -0.36 | +0.07 | +16.28% |
| Nov 4, 2025 | Sep 30, 2025 | -0.43 | -0.37 | +0.06 | +13.95% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | Canaccord Genuity | main | Buy | Buy |
| Oct 2, 2026 | TD Cowen | main | Buy | Buy |
| Sep 11, 2026 | BTIG | reit | Buy | Buy |
| Aug 18, 2026 | BTIG | main | Buy | Buy |
| Aug 11, 2026 | Canaccord Genuity | main | Buy | Buy |
| Aug 11, 2026 | BTIG | reit | Buy | Buy |
About CeriBell, Inc.
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- ceribell.com
News
Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $33 
CeriBell, Inc. (CBLL) Reports Q3 Loss, Tops Revenue Estimates 
CeriBell, Inc. (CBLL) Q3 2026 Earnings Call Transcript 
Compared to Estimates, CeriBell, Inc. (CBLL) Q3 Earnings: A Look at Key Metrics 
CeriBell Q3 Earnings Call Highlights 
CeriBell Q3 2026 Earnings Call Transcript 
CeriBell Raises FY2026 Sales Guidance from $114.000M-$117.000M to $115.000M-$117.000M vs $115.537M Est 
CeriBell Q3 EPS $(0.55) Misses $(0.51) Estimate, Sales $29.341M Beat $29.164M Estimate 
Ceribell Reports Third Quarter 2026 Financial Results 
Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
Your note
Sign in to keep a note on CBLL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BLUMBERG SCOTT | Chief Financial Officer | Sale | Sep 14, 2026 | 146,600 |
| CHAO XINGJUAN | Chief Executive Officer | Sale | Sep 14, 2026 | 1,115,430 |
| FOEHR DAVID | Officer | Sale | Sep 7, 2026 | 34,144 |
| MANNI JOSEPH S | Officer | Sale | Aug 20, 2026 | 55,956 |
| PARVIZI JOSEF | Director | Stock Award(Grant) | Jun 1, 2026 | 2,007,490 |
| ROGERS ERICA J. | Director | Stock Award(Grant) | Jun 1, 2026 | 33,054 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.66% | 5,691,393 | 148.03M | Jun 29, 2026 |
| TPG GP A, LLC | 9.68% | 3,761,154 | 97.83M | Jun 29, 2026 |
| Red Tree Management, LLC | 5.68% | 2,205,661 | 57.37M | Sep 29, 2026 |
| Blackrock Inc. | 4.99% | 1,936,093 | 50.36M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 2.91% | 1,130,346 | 29.40M | Jun 29, 2026 |
| KCM Capital Inc | 2.90% | 1,125,000 | 29.26M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 4.22% | 1,637,485 | 42.59M | Jul 30, 2026 |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 2.64% | 1,024,969 | 26.66M | Aug 30, 2026 |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 2.42% | 939,251 | 24.43M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.19% | 850,443 | 22.12M | Jun 29, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund | 2.14% | 830,545 | 21.60M | Jul 30, 2026 |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 1.93% | 750,219 | 19.51M | Jul 30, 2026 |